- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01560897
Investigating Project of the Functional C13 Test "Pilot Study" (PIL001)
July 30, 2012 updated by: Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Investigating Project of the Functional C13 Test
The aim of this pilot study is to evaluate the validity and reproducibility of a functional test "Test C13" ureogenesis to measure in vivo, using the methodology Laboratory of Metabolic Diseases of "Cliniques Universitaires Saint-Luc"
Study Overview
Study Type
Interventional
Enrollment (Anticipated)
10
Phase
- Phase 2
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Sokal Etienne, Professor
- Phone Number: 02 764 19 33
Study Locations
-
-
-
Brussels, Belgium
- Recruiting
- Cliniques Saint Luc
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
2 years to 50 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- healthy or with a disorder of the urea cycle
Exclusion Criteria:
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: C13
The dose of sodium [1-13C] acetate is calculated according to patient weight (27mg/kg) or (0.33 mmol / kg).
|
Ingestion of C13 and follow up of the ureogenesis
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Subject with a disorder of the urea cycle
Time Frame: Day 1
|
Day 1
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2012
Primary Completion (Anticipated)
December 1, 2012
Study Registration Dates
First Submitted
March 20, 2012
First Submitted That Met QC Criteria
March 21, 2012
First Posted (Estimate)
March 22, 2012
Study Record Updates
Last Update Posted (Estimate)
July 31, 2012
Last Update Submitted That Met QC Criteria
July 30, 2012
Last Verified
July 1, 2012
More Information
Terms related to this study
Other Study ID Numbers
- Pilot Study
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Disorder of the Urea Cycle
-
Nutricia ResearchCompletedInborn Errors of Metabolism | Urea Cycle DisorderUnited States
-
Horizon Therapeutics, LLCCompletedUrea Cycle DisorderUnited States, Spain, Italy, Switzerland
-
Istanbul University - Cerrahpasa (IUC)CompletedUrea Cycle Disorder | Lysinuric Protein IntoleranceTurkey
-
Emma Marie Caroline SlackUniversity Children's HospitalCompletedInborn Errors of Metabolism | Propionic Aciduria | Methylmalonic Aciduria | Urea Cycle DisorderSwitzerland
-
Horizon Therapeutics, LLCTerminatedUrea Cycle DisorderUnited States
-
SynlogicCompletedHealthy Volunteer | Urea Cycle DisorderUnited States
-
University of AarhusRecruiting
-
Baylor College of MedicineSeattle Children's Hospital; University of California, San FranciscoCompleted
-
Kaleido BiosciencesTerminatedUrea Cycle DisorderBelgium, United States, Spain, United Kingdom, Germany, Switzerland, Turkey
Clinical Trials on Oral C13
-
Chongqing Medical UniversityUnknown
-
Robert Bok, MD, PhDNational Cancer Institute (NCI)RecruitingAdult Gliomas, MixedUnited States
-
University Hospital, GrenobleNational Cancer Institute, FranceTerminated
-
Meridian Bioscience, Inc.CompletedChronic Liver DiseaseUnited States, Israel
-
Robert Flavell, MD, PhDU.S. Army Medical Research Acquisition ActivityRecruitingProstate Cancer | Localized Prostate CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Refractory Pancreatic Carcinoma | Stage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Stage IV Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB... and other conditionsUnited States
-
Rahul AggarwalNational Cancer Institute (NCI)RecruitingProstate Cancer | Advanced Prostate CarcinomaUnited States
-
University of Erlangen-Nürnberg Medical SchoolCompletedH. Pylori InfectionGermany
-
Children's Hospital Medical Center, CincinnatiNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Javier Villaneuva-Meyer, MDNational Institute for Biomedical Imaging and Bioengineering (NIBIB); General...RecruitingMeningiomaUnited States